Pulling SEC filings + quote and writing the call…

MediWound Ltd.
Next earnings Aug 12, 2026 · consensus $-0.78 EPS, $2.64M rev
Mixed signals in the latest filings.
MediWound Ltd. shows limited reported revenue.
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001593984, latest 4 filed 2026-06-04) · EODHD · as of 6/28/2026, 4:58:44 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 6 open-market buys · 0 sales
| 2026-06-03 | SHAMIR NACHUM Director | Buy | 175.00 @ $13.98 | $2.45K |
| 2026-06-03 | SHAMIR NACHUM Director | Buy | 5.83K @ $14.00 | $81.5K |
| 2026-06-01 | Fox David Morton Director | Buy | 1.73K @ $14.23 | $24.6K |
| 2026-06-01 | Fox David Morton Director | Buy | 10.00 @ $14.23 | $142.30 |
| 2026-06-01 | Fox David Morton Director | Buy | 1.80K @ $14.00 | $25.1K |
| 2026-05-29 | Rubinstein Samuel Director | Buy | 150.00 @ $14.33 | $2.15K |
1043 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.